There are 2789 resources available
1128P - Genotypic and phenotypic evaluation of the pharmacokinetics of irinotecan and its relationship with the occurrence of toxicity in the treatment of cancer
Presenter: Jeziel Basso
Session: ePoster Display
1129P - Comparison of predictive value of ASIA criteria and PD-L1 expression in patients taking checkpoint inhibitors in real clinical practice
Presenter: Natalia Zhukova
Session: ePoster Display
1061P - Safety of cemiplimab for advanced cutaneous squamous cell carcinoma: The Spanish named patient programme
Presenter: Almudena Garcia Castano
Session: ePoster Display
Resources:
Abstract
1062P - Real-world data on clinical outcome and tolerability in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab in the Netherlands
Presenter: Maartje Rohaan
Session: ePoster Display
1133P - Whole genome sequencing can classify diagnostically challenging tumors
Presenter: Luuk Schipper
Session: ePoster Display
1064P - Final results of CA209-9JC: A phase II study of first-line nivolumab in patients with advanced cutaneous squamous cell carcinoma
Presenter: Rodrigo Ramella Munhoz
Session: ePoster Display
1065P - A retrospective multicenter Italian analysis of the effect of longer vismodegib intake in 68 basal cell carcinoma patients who achieved clinical complete remission
Presenter: Salvatore Alfieri
Session: ePoster Display
1066P - Extended-dose cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Primary analysis of phase II results
Presenter: Danny Rischin
Session: ePoster Display
1067P - Correlation between the number of risk factors and relapse in patients with cutaneous squamous cell carcinoma: A predictive factor for accurate adjuvant radiotherapy?
Presenter: Adeline Petre
Session: ePoster Display
1068P - Efficacy of combined hypo-fractionated radiotherapy (RT) in anti-PD-1 monotherapy-treated melanoma pts
Presenter: Philippe Saiag
Session: ePoster Display